Bosutinib

• Description:

  Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  530.45

• Molecular Formula:

  C26H29Cl2N5O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Abl| MAPK| c-Src

• CAS Number:

  380843-75-4